Sen. Susan Collins has an urgent warning about the state of biomedical research in the United States, saying the country could lose its edge if it continues on its current track.
At the Senate Appropriations Committee’s first full hearing this Congress Wednesday, Collins, the Maine Republican who chairs the panel, called on the Trump administration to reverse course on cutbacks. She cited the administration’s cap on indirect research costs, the canceling of grants and the mass firing of employees across the Health and Human Services Department.
“These actions put our leadership in biomedical innovation at real risk and must be reversed,” she said.
